Marinomed Biotech AG

Declaration of Voting Results & Voting Rights Announcements • Feb 27, 2020

Publication Date: 27.02.2020 15:36 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Overview

Notification made after deadline Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights) 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Acquisition or disposal of voting rights 3. Person subject to notification obligation Acting in concert agreement (Sec. 133 No. 1 BörseG 2018) Name: Conseq Invest Akcie Nové Evropy City: Dublin Country: Ireland Name: Conseq globální akciový úcastnický fond City: Prague Country: Czech Republic 4. Name of shareholder(s): 5. Date on which the threshold was crossed or reached: 27.1.2020 6. Total positions

_____________________________________________________________________________ | | | % of voting | | | | | % of voting |rights through | |Total number of| | |rights attached|financial/other|Total of both | voting rights | | |to shares (7.A)| instruments |in % (7.A + | of issuer | |_____________|_______________|(7.B.1_+_7.B.2)|7.B)___________|_______________| | Resulting | | | | | |situation on | | | | | | the date on | | | | | | which | 4.08 % | 0.00 % | 4.08 %|1,469,770 | | threshold | | | | | |was crossed /| | | | | |___reached___|_______________|_______________|_______________|_______________| |Position of | | | | | |previous | | | | | |notification | | | | | |(if | | | | | |applicable)__|_______________|_______________|_______________|_______________|

Details 7. Notified details of the resulting situation:

		____________
A:Voting_rights_attached_to_shares______
			Number_of_voting_rights_ %of_voting_rights_____
	Direct	Indirect (Sec	Direct	Indirect (Sec
ISIN Code	(Sec 130 BörseG 133 BörseG		(Sec 130 BörseG 133 BörseG
				__ 2018)__ _2018)_ __2018)_ 2018)___
				AT0000831706 __ __________60,000 _______________ __________4.08%
				SUBTOTAL_A__ ____60,000 ______4.08_%

		______________
		B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1
		BörseG_2018_________
			Number of voting
			rights that may
Type of	Expiration Date		Exercise Period be acquired if	% of voting
instrument			the instrument is rights
		_ __ __ _exercised _____
		_ __ __ __ _
		____ SUBTOTALB.1 ___ _____

____________ B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG_2018_____________
Type of	Date	Period	Expiration Exercise Physical / Cash Number of Settlement instrument _ _ ___ __ __	voting rights rights	% of voting
			_ _ _ __ ___ _ ______________________________ SUBTOTAL_B.2__ ____ _____

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

					____________
				Financial/
		Directly	Shares held	other	Total of both
No.	Name		controlled directly (%) instruments		(%)
		by No.		held
					__ _ ___ __ directly_(%) _____
					__1 _Jan_Vedral _ 0.00% _0.00% _____0.00_%
	Conseq
2	Investment		1 0.00 %	0.00 %	0.00 %
	Management,
					__ __a.s. _ ___ __ _____
	Conseq
3	Penzijní		2 0.00 %	0.00 %	0.00 %
	spole¿nost,
					__ __a.s. _ ___ __ _____
	Conseq
	globální

4	akciový	3	2.33 %	0.00 %	2.33 %
	úcastnický
					__ __fond _ ___ __ _____
5	Conseq		0.00 %	0.00 %	0.00 %
					__ Invest_Plc __ _ ___ _______
	Conseq
	6 Invest Akcie	5	1.75 %	0.00 %	1.75 %
					__ _Nové_Evropy _ ___ __ _____

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights.

2. Other comments: Shares are held by two investment funds managed by investment companies as stated above acting in concert.

Further inquiry note: Dr. Eva Prieschl-Grassauer Chief Scientific Officer, Marinomed Veterinärplatz 1, 1210 Vienna, Austria T +43 (0)1 250 77 4460 E-Mail: eva.prieschl@marinomed.com http://www.marinomed.com

Roland Mayrl Managing Partner, Metrum Communications Bauernmarkt 10/19, 1010 Vienna, Austria T +43 (0) 1 504 69 87 331 E-Mail: r.mayrl@metrum.at http://www.metrum.at

end of announcement euro adhoc

---

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

	Aussendung übermittelt durch euro adhoc
	The European Investor Relations Service